Purpose of the Test
- Identify mutations in the EGFR gene.
- Guide physicians in selecting targeted therapy (TKIs).
- Avoid unnecessary chemotherapy treatments.
Book EGFR Mutation Test in Saudi Arabia | Lahalak Medical Platform
A precise genetic test for non-small cell lung cancer patients, helping doctors identify the most effective targeted therapy, significantly improving treatment response and overall health outcomes for patients.
Scientific name: EGFR Mutation Analysis for Lung Cancer
This test analyzes cancer cell DNA to detect Epidermal Growth Factor Receptor (EGFR) mutations. It determines patient eligibility for targeted Tyrosine Kinase Inhibitor (TKI) therapies in lung cancer cases.
Service type
Molecular Genetic Test
Duration
7-10 working days
Fasting
Fasting is not required
Included Services
- Blood sample collection or tissue pickup
- Genetic sequencing for mutations
- Detailed medical report
Medical Service Information
Target Groups
- Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
- Patients planning to start targeted therapy.
- Cases monitoring disease progression or drug resistance.
Required Preparations
- Fasting is not required before the test.
- Test can be done via blood (Liquid Biopsy) or tissue sample.
- Inform the lab about any current oncological treatments.
Conditions & Notices
- Previous medical reports must be provided
- Oncologist consultation is recommended before testing
Medical services you might also like
